" /> B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 - CISMeF





Preferred Label : B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1;

NCIt synonyms : B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1); B Lymphoblastic Leukemia Lymphoma with t 1 19 q23 p13 3 E2A-PBX1 TCF3-PBX1; B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3::PBX1; B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1); B Lymphoblastic Leukemia/Lymphoma with TCF3::PBX1 Fusion; B Lymphoblastic Leukemia/Lymphoma with TCF3-PBX1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with TCF3-PBX1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with TCF3::PBX1 Fusion;

NCIt definition : A precursor lymphoid neoplasm which is composed of B lymphoblasts and carries a translocation between the E2A gene on chromosome 19 and the PBX1 gene on chromosome 1.;

Neoplastic status : Malignant;

ICD-O code : 9818/3;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.